Form 8-K - Current report:
SEC Accession No. 0001739104-25-000011
Filing Date
2025-02-25
Accepted
2025-02-25 07:05:31
Documents
15
Period of Report
2025-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K DATED FEBRUARY 25, 2025 elan-20250225.htm   iXBRL 8-K 27262
2 EXHIBIT 99.1 PRESS RELEASE DATED FEBRUARY 25, 2025 elanco-12312024exhibit991.htm EX-99.1 387140
6 GRAPHIC image1a.jpg GRAPHIC 214321
  Complete submission text file 0001739104-25-000011.txt   833633

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20250225.xsd EX-101.SCH 1792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20250225_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20250225_pre.xml EX-101.PRE 12518
17 EXTRACTED XBRL INSTANCE DOCUMENT elan-20250225_htm.xml XML 2703
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 25659345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)